FRESENIUS KABI USA FDA Approval ANDA 206254

ANDA 206254

FRESENIUS KABI USA

FDA Drug Application

Application #206254

Application Sponsors

ANDA 206254FRESENIUS KABI USA

Marketing Status

Prescription001

Application Products

001POWDER;INTRAVENOUS10MG/VIAL0ROMIDEPSINROMIDEPSIN

FDA Submissions

UNKNOWN; ORIG1AP2021-10-12STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

FRESENIUS KABI USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206254
            [companyName] => FRESENIUS KABI USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ROMIDEPSIN","activeIngredients":"ROMIDEPSIN","strength":"10MG\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/12\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-10-12
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.